- Published on
Medicine – Causes of Thrombophilia
Thrombophilia is an inherited or acquired tendency to develop thrombosis due to abnormalities in the coagulation system or other prothrombotic mechanisms.
Thrombophilia predominantly predisposes to venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). Certain acquired conditions, particularly antiphospholipid syndrome, may cause both venous and arterial thrombosis.
Thrombophilia is classified into inherited and acquired causes. Inherited thrombophilias commonly involve deficiencies of natural anticoagulants or mutations affecting coagulation factors. Acquired thrombophilia may result from autoimmune disease, hormonal therapy, malignancy or systemic illness.
1. Inherited Thrombophilia
Inherited thrombophilias are genetic abnormalities that increase the tendency to develop venous thrombosis.
A. Antithrombin Deficiency
Antithrombin, previously called antithrombin III, is a naturally occurring anticoagulant produced mainly by the liver.
- Inheritance: Usually autosomal dominant.
- Normal function: Inhibits thrombin (factor IIa), factor Xa and, to a lesser extent, factors IXa, XIa and XIIa.
- Deficiency: Causes increased thrombin generation and venous thrombosis.
- Clinical significance: One of the higher-risk inherited thrombophilias.
Heparin enhances antithrombin activity. Severe antithrombin deficiency may reduce the anticoagulant response to heparin.
B. Protein C Deficiency
Protein C is a vitamin K-dependent natural anticoagulant.
- Inheritance: Usually autosomal dominant.
- Normal function: Activated protein C, with protein S as a cofactor, inactivates factors Va and VIIIa.
- Deficiency: Causes increased coagulation and venous thrombosis.
- Severe deficiency: May cause neonatal purpura fulminans.
Protein C levels can be reduced by vitamin K antagonists, liver disease and acute illness, which may complicate laboratory testing.
C. Protein S Deficiency
Protein S is a vitamin K-dependent anticoagulant protein.
- Inheritance: Usually autosomal dominant.
- Normal function: Acts as a cofactor for activated protein C.
- Mechanism: Facilitates inactivation of factors Va and VIIIa.
- Deficiency: Increases the risk of venous thrombosis.
Illustration: Natural Anticoagulant Pathways
D. Factor V Leiden Mutation
Factor V Leiden is a genetic mutation that causes resistance to activated protein C.
- Inheritance: Autosomal dominant pattern of thrombophilia susceptibility, with incomplete penetrance.
- Genetic defect: Point mutation in the F5 gene.
- Mechanism: Factor V becomes resistant to normal inactivation by activated protein C.
- Result: Increased thrombin generation and venous thrombosis.
Factor V Leiden is the most common inherited thrombophilia in populations of European ancestry.
It occurs in approximately 3–8% of people of European ancestry, but is much less common in many Asian and African populations. The historical figure of 5% should therefore not be applied worldwide.
Heterozygous factor V Leiden generally confers a lower thrombotic risk than antithrombin deficiency, whereas homozygous factor V Leiden carries a substantially greater risk.
Illustration: Factor V Leiden Mechanism
E. Prothrombin G20210A Mutation
The prothrombin G20210A mutation is another important inherited thrombophilia.
- Associated with increased prothrombin levels.
- Promotes increased thrombin generation.
- Predisposes to venous thrombosis.
- Generally confers a lower thrombotic risk than antithrombin deficiency.
2. Mind Map – Causes of Thrombophilia
The following mind map summarises inherited and acquired thrombophilia.
Major inherited and acquired causes of thrombophilia. APS may also cause arterial thrombosis.
3. Acquired Thrombophilia
A. Antiphospholipid Syndrome (APS)
Antiphospholipid syndrome is an autoimmune disorder characterised by persistent antiphospholipid antibodies associated with thrombosis and/or certain pregnancy complications.
Important antibodies:
- Lupus anticoagulant.
- Anticardiolipin antibodies.
- Anti-β2-glycoprotein I antibodies.
Clinical manifestations:
- Deep vein thrombosis.
- Pulmonary embolism.
- Arterial thrombosis, including stroke.
- Recurrent pregnancy loss and other obstetric complications.
B. Oral Contraceptives, Oestrogens and Tamoxifen
Oestrogen-containing medications may increase thrombotic risk by altering the balance between procoagulant and anticoagulant pathways.
Important examples include:
- Combined oral contraceptive pills.
- Certain hormone replacement therapies.
- Tamoxifen, a selective oestrogen receptor modulator used in breast cancer treatment.
C. Nephrotic Syndrome
Nephrotic syndrome produces an acquired hypercoagulable state through several mechanisms.
- Urinary loss of anticoagulant proteins, including antithrombin.
- Increased hepatic synthesis of coagulation factors.
- Changes in platelet activity.
- Haemoconcentration in some patients.
Renal vein thrombosis, DVT and pulmonary embolism are recognised complications.
D. Cancer
Malignancy increases the risk of thrombosis through tumour-associated procoagulant activity, inflammation, endothelial activation and treatment-related factors.
Particularly important examples include pancreatic cancer, gastric cancer and other advanced malignancies.
Mucin-producing adenocarcinomas may be associated with Trousseau syndrome, classically presenting as migratory thrombophlebitis.
E. Inflammatory Bowel Disease
Both Crohn disease and ulcerative colitis are associated with increased VTE risk.
Contributing factors include:
- Systemic inflammation.
- Increased coagulation activity.
- Hospitalisation and immobility.
- Dehydration.
- Surgery.
The risk is particularly increased during active disease flares.
F. Other Acquired Causes
- Pregnancy and the puerperium.
- Major surgery.
- Prolonged immobility.
- Heparin-induced thrombocytopenia.
- Myeloproliferative neoplasms.
4. Comparison of Inherited Thrombophilias
| Disorder | Mechanism | Important Association |
|---|---|---|
| Antithrombin deficiency | Reduced inhibition of thrombin and factor Xa | Higher-risk inherited thrombophilia |
| Protein C deficiency | Reduced inactivation of factors Va and VIIIa | VTE; severe deficiency may cause neonatal purpura fulminans |
| Protein S deficiency | Reduced cofactor activity for activated protein C | Increased VTE risk |
| Factor V Leiden | Resistance to activated protein C | Common inherited thrombophilia in European populations |
| Prothrombin G20210A | Increased prothrombin levels | Increased venous thrombosis risk |
5. Clinical Clues Suggesting Thrombophilia
An underlying thrombophilic disorder may be considered in patients with:
- Recurrent episodes of venous thromboembolism.
- VTE at a young age, particularly without major provoking factors.
- A strong family history of venous thrombosis.
- Thrombosis at unusual sites, such as cerebral or splanchnic veins.
- Venous or arterial thrombosis associated with features of antiphospholipid syndrome.
- Severe or recurrent pregnancy complications suggestive of antiphospholipid syndrome.
6. High-Yield Examination Summary
| Category | Important Causes |
|---|---|
| Inherited – anticoagulant deficiencies | Antithrombin, protein C, protein S deficiency |
| Inherited – coagulation factor mutations | Factor V Leiden, prothrombin G20210A |
| Autoimmune | Antiphospholipid syndrome |
| Hormonal / medication | Oestrogen, combined OCP, tamoxifen |
| Renal | Nephrotic syndrome |
| Malignancy | Cancer-associated hypercoagulability |
| Inflammatory | Crohn disease, ulcerative colitis |
| Other acquired | Pregnancy, puerperium, surgery, HIT, myeloproliferative neoplasms |
7. Key Examination Pearls
- Antithrombin inhibits thrombin and factor Xa, as well as several other activated coagulation factors.
- Activated protein C inactivates factors Va and VIIIa.
- Protein S acts as a cofactor for activated protein C.
- Factor V Leiden causes activated protein C resistance.
- Factor V Leiden is the most common inherited thrombophilia in populations of European ancestry.
- Antithrombin, protein C and protein S deficiencies are usually inherited in an autosomal dominant pattern.
- Antiphospholipid syndrome may cause both arterial and venous thrombosis.
- Lupus anticoagulant may prolong aPTT while increasing thrombotic risk.
- Nephrotic syndrome, malignancy, oestrogen therapy and inflammatory bowel disease are important acquired causes.
Inherited thrombophilias predominantly predispose to venous thrombosis. Factor V Leiden causes activated protein C resistance, while antithrombin, protein C and protein S deficiencies impair natural anticoagulation. Antiphospholipid syndrome is an important acquired thrombophilia that can cause both venous and arterial thrombosis.
This article is intended for medical education and examination revision. Thrombophilia testing and management should be individualised according to clinical history, thrombotic risk and current guidelines. Testing during acute thrombosis or anticoagulant treatment may produce misleading results.
Kembara Xtra – Medicine Revision Notes